NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinomaXiao-Ping Zhong, Rong Guo, Jie Mei et al.|Cell Death and Disease|2019Cited by 49
Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinomaLiang-He Lu, Rong Guo, Yong‐Fa Zhang et al.|Digestive and Liver Disease|2019Cited by 40
Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma PatientsLiang-He Lu, Rong Guo, Yong‐Fa Zhang et al.|Journal of Gastrointestinal Surgery|2017Cited by 31
Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 casesShaohua Li, Rong Guo, Wei Wei et al.|Journal of Cancer|2019Cited by 5